VHL-dependence of EHHADH expression in a human renal cell carcinoma cell line
Abstract: The von Hippel-Lindau tumor suppressor gene (VHL) is mutated in up to 90% of clear cell renal cell carcinoma (ccRCC) cases, thus playing a key role in ccRCC pathogenesis. ccRCC can be classified as a metabolic disease in which alterations in fatty acid metabolism facilitate cancer cell proliferation. Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase (EHHADH) is an enzyme involved in peroxisomal fatty acid degradation. It is primarily expressed in renal proximal tubule cells, presumably the origin of ccRCC. Although EHHADH is still a relatively unexplored gene, it is known to be differentially expressed in several tumors. In this study, analysis of several databases revealed that EHHADH expression is downregulated in ccRCC samples compared to healthy kidney samples. Moreover, cell culture experiments were performed to investigate the relationship between EHHADH and VHL at the gene and protein level. qPCR and Western blot analyses using the human ccRCC cell line RCC4 revealed that EHHADH is expressed in a VHL-dependent manner. RCC4 cells reconstituted with VHL show significantly higher EHHADH mRNA and protein levels than VHL-deficient RCC4 control cells. These results indicate that the downregulation of EHHADH in ccRCC reported may be due to the loss of VHL function. This study is the first to molecularly characterize EHHADH, a key enzyme in peroxisomal ß-oxidation, in relation to VHL, suggesting a potential pathogenic interaction that is worthy of further investigation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Journal of kidney cancer and VHL. - 11, 1 (2024) , 12-18, ISSN: 2203-5826
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2024
- Urheber
- DOI
-
10.15586/jkcvhl.v11i1.322
- URN
-
urn:nbn:de:bsz:25-freidok-2440059
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
Entstanden
- 2024
Ähnliche Objekte (12)
CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
Zafirlukast induces VHL- and HIF-2α-dependent oxidative cell death in 786-O clear cell renal carcinoma cells
Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas
Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
Ubiquitination of MAP1LC3B by pVHL is associated with autophagy and cell death in renal cell carcinoma
8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness
Identification of 3 novel VHL germ-line mutations in Danish VHL patients
VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
GPC3 reduces cell proliferation in renal carcinoma cell lines
HIF-2α downregulation in the absence of functional VHL is not sufficient for renal cell differentiation
CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
Zafirlukast induces VHL- and HIF-2α-dependent oxidative cell death in 786-O clear cell renal carcinoma cells
Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas
Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
Ubiquitination of MAP1LC3B by pVHL is associated with autophagy and cell death in renal cell carcinoma
8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness
Identification of 3 novel VHL germ-line mutations in Danish VHL patients
VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
GPC3 reduces cell proliferation in renal carcinoma cell lines
HIF-2α downregulation in the absence of functional VHL is not sufficient for renal cell differentiation
CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
Zafirlukast induces VHL- and HIF-2α-dependent oxidative cell death in 786-O clear cell renal carcinoma cells
Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas
Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
Ubiquitination of MAP1LC3B by pVHL is associated with autophagy and cell death in renal cell carcinoma
8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness
Identification of 3 novel VHL germ-line mutations in Danish VHL patients
VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
GPC3 reduces cell proliferation in renal carcinoma cell lines